Sources | Names Used |
---|---|
CTRPv2 | selumetinib:piperlongumine (8:1 mol/mol) |
PharmacoGx | selumetinib:piperlongumine (8:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ANO10 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | SNX15 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | TWSG1 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | SHCBP1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | RP11-382A20.3 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
mRNA | SIRPA | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0007 |
mRNA | C1QTNF8 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | TBL1X | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | ERCC2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | C5orf47 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |